Lauren M. Cornall
Melbourne, VIC 8001, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity.
Journal: International journal of molecular sciences
Published: June 18, 2020
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity.
Journal: Molecular and cellular endocrinology
Published: August 21, 2014
Increased pyruvate dehydrogenase kinase expression in cultured myotubes from obese and diabetic individuals.
Journal: European journal of nutrition
Published: December 17, 2013
GPR120 agonism as a countermeasure against metabolic diseases.
Journal: Drug discovery today
Published: July 31, 2013
The therapeutic potential of GPR43: a novel role in modulating metabolic health.
Journal: Cellular and molecular life sciences : CMLS
Published: April 30, 2013
Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
Journal: Expert opinion on investigational drugs
Published: February 28, 2013
GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes.
Journal: Molecular and cellular endocrinology
Published: March 22, 2012
Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: October 10, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026